Arkolith/Insider Trading/JAGX/Form 4

Siegel Jonathan B.

DirectorJaguar Health, Inc. (JAGX) · full profile →Form 4 · filed Jun 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2025Disposed to issuer(D)9K$50000.00$450.0M0
Jun 24, 2025Grant(A)18K——9K
Jun 24, 2025Grant(A)9K$50000.00$473.1M9K

Transaction Codes

D
Disposition to the issuer
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-090452) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML